- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Hong Kong Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
6
3 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
6 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
6826 New | HK$26.70 | 1.5% | 2.6% | HK$13.1b | HK$42.57 | PE13.6x | E20.1% | 3.2% | ||
1801 New | HK$41.70 | 11.2% | 4.8% | HK$68.3b | HK$53.36 | PS8.6x | E44.0% | n/a | ||
9926 New | HK$68.95 | 14.5% | 51.4% | HK$61.9b | HK$76.99 | PS30.8x | E43.8% | n/a | ||
6990 | HK$213.40 | 16.9% | 100.4% | HK$48.5b | HK$222.81 | PS24.1x | E5.1% | n/a | ||
1548 | HK$13.22 | 10.4% | -11.3% | HK$28.4b | HK$22.72 | PS3.6x | E111.3% | 0% | ||
2268 | HK$37.65 | 25.3% | 111.8% | HK$45.1b | HK$36.86 | PE70.9x | E26.9% | n/a |
Page 1 of 1